Corient Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,997
| Closed | -$551K | – | 735 |
|
|
2021
Q2 | $551K | Buy |
2,997
+255
| +9% | +$46.9K | 0.04% | 336 |
|
|
2021
Q1 | $420K | Buy |
2,742
+378
| +16% | +$57.9K | 0.04% | 355 |
|
|
2020
Q4 | $369K | Buy |
2,364
+508
| +27% | +$79.3K | 0.04% | 333 |
|
|
2020
Q3 | $212K | Sell |
1,856
-150
| -7% | -$17.1K | 0.02% | 437 |
|
|
2020
Q2 | $225K | Buy |
+2,006
| New | +$225K | 0.03% | 407 |
|
|
2019
Q4 | – | Sell |
-8,401
| Closed | -$822K | – | 491 |
|
|
2019
Q3 | $822K | Buy |
+8,401
| New | +$822K | 0.12% | 187 |
|